ICER Supports Hemophilia Gene Therapies Based on Clinical, Cost Review
September 16th 2022A draft report released from the Institute for Clinical and Economic Review (ICER) compared the benefits of etranacogene dezaparvovec (EtranaDez) and valoctocogene roxaparvovec (val-rox) to current treatments.
Read More